Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Articles online first > Minerva Endocrinologica 2016 Sep 14

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

MINERVA ENDOCRINOLOGICA

Rivista sulle Malattie del Sistema Endocrino


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383


eTOC

 

Minerva Endocrinologica 2016 Sep 14

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Ruminant trans-fatty acids and risk of breast cancer: a systematic review and meta-analysis of observational studies

Roya KOLAHDOUZ MOHAMMADI 1, Minoo BAGHERI 2, Mina KOLAHDOUZ MOHAMMADI 3, Farzad SHIDFAR 1

1 Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran; 2 Department of Community Nutrition, School of Nutritional Sciences and Dietetic, Tehran University of Medical Sciences, Tehran, Iran; 3 Cellular & Molecular Biology Department, International Kish Campus, University of Tehran, Tehran, Iran


PDF  


INTRODUCTION: R-TFA (ruminant trans-fatty acids) especially cis9, trans11-conjugated linoleic acid (c9,t11-CLA) and trans11-18:1 vaccenic acid (t11-18:1 VA) appear to have anticarcinogenic activity against breast cancer in animal and in vitro experiments. However, the results remain inconsistent. We therefore conducted a systematic review and meta- analysis to assess the association of c9,t11-CLA, and t11-18:1 VA (intake or serum levels) with breast cancer risk.
EVIDENCE ACQUISITION: Relevant studies were identified by a search of PubMed, OVID, SCOPUS and Google scholar databases through 25 May 2015. We included case- control and cohort studies that reported relative risk (RR) estimates with 95% confidence intervals (CIs) for the association between c9,t11-CLA and t11-18:1 VA intake or their serum levels and the risk of breast cancer. This metaanalysis was conducted according to the guidelines for the meta-analysis of observational studies in epidemiology.
EVIDENCE SYNTHESIS: Three studies on c9,t11-CLA and t11-18:1 VA serum levels and t11-18:1 VA intake were evaluated in the systematic review only (narrative synthesis) and four studies (2 case-control and 2 cohort studies on c9,t11-CLA intake) were included in the meta-analysis (quantitative synthesis). The pooled RR for the highest vs lowest category of c9,t11-CLA intake was 0.94 (95% CI: 0.64–1.25) with evidence of heterogeneity (with 67,533 participants, I2= 78.3%, p= 0.003). Studies that could not be included in the quantitative syntheses were inconclusive.
CONCLUSIONS: No association was found between c9,t11-CLA intake and breast cancer risk, but the number of studies identified was small.

inizio pagina

Publication History

Per citare questo articolo

Kolahdouz Mohammadi R, Bagheri M, Kolahdouz Mohammadi M, Shidfar F. Ruminant trans-fatty acids and risk of breast cancer: a systematic review and meta-analysis of observational studies. Minerva Endocrinol 2016 Sep 14. 

Corresponding author e-mail

shidfar.f@iums.ac.ir